🔗 Permalink

Assignee profile:

Osiris Therapeutics, Inc.

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2012-08-23

Patent Grants:

Last grant date:

2013-07-16

Top Inventors for applications by Osiris Therapeutics, Inc.

These are the the leading inventors for applications assigned to Osiris Therapeutics, Inc.:

Mark F. Pittenger 4 Severna Park, MD United States
Alastair Morgan Mackay 3 Timonium, MD United States
Stephen L. Gordon 3 Columbia, MD United States
Joseph D. Mosca 3 Ellicott City, MD United States

Bradley J. Martin 3 Ellicott City, MD United States
Kevin R. McIntosh 2 Ellicott City, MD United States
Stephen L. Gordon 2 Rockville, MD United States
Bradley J. Martin 2 Ellicot City, MD United States

Elena Klyushnenkova 1 Baltimore, MD United States
Rodney Monroy 1 Aberdeen, MD United States
Alastair Morgan Mackay 1 Towson, MD United States
Scott P. Bruder 1 Waltham, MA United States

Daniel R. Marshak 1 Lutherville, MD United States
Elena N. Klyushnenkova 1 Baltimore, MD United States
Michelle Marcelino 1 Ijamsville, MD United States
Scott P. Bruder 1 Owings Mills, MD United States

Alicia Tyrell 1 Catonsville, MD United States
Alicia Tyrell 1 Cantonsville, MD United States
Simon Bubnic 1 Ann Arbor, MI United States
Diane Carter 1 Huntington, MD United States

Sudhakar Kadiyala 1 Baltimore, MD United States
Kevin R. Mc Intosh 1 Ellicott City, MD United States
Michelle Marcelino 1 Ijamville, MD United States
Joseph Mosca 1 Ellicott City, MD United States

Alla Danilkovitch 1 Columbia, MD United States

Recent patent applications by Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc. based in Baltimore, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-08-23 ✅ Patent 8,486,695 granted on 2013-07-16

US20120214178A1

Chemistry; metallurgy

Mesenchymal stem cells expressing TNF-alpha receptors

#2 | 2011-06-30 ✅ Patent 8,158,121 granted on 2012-04-17

US20110158965A1

Human necessities

Cardiac muscle regeneration using mesenchymal stem cells

#3 | 2010-07-08 ✅ Patent 8,158,120 granted on 2012-04-17

US20100172884A1

Human necessities

Cardiac muscle repair or regeneration using bone marrow-derived stem cells

#4 | 2009-08-27 ✅ Patent 7,892,829 granted on 2011-02-22

US20090214493A1

Human necessities

Cardiac muscle regeneration using mesenchymal stem cells

#5 | 2009-02-17 ✅ Patent 7,491,388 granted on 2009-02-17

US9807810

Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation

#6 | 2006-09-05 ✅ Patent 7,101,704 granted on 2006-09-05

US9638358

Antigen presenting mesenchymal stem cells

#7 | 2006-04-18 ✅ Patent 7,029,666 granted on 2006-04-18

US10046530

Uses for non-autologous mesenchymal stem cells

#8 | 2005-05-26 ✅ Patent 7,514,074 granted on 2009-04-07

US20050112104A1

Human necessities

Cardiac muscle regeneration using mesenchymal stem cells

#9 | 2005-04-05 ✅ Patent 6,875,430 granted on 2005-04-05

US10067121

Mesenchymal stem cells for prevention and treatment of immune responses in transplantation

#10 | 2005-03-08 ✅ Patent 6,863,900 granted on 2005-03-08

US9840284

Regeneration and augmentation of bone using mesenchymal stem cells

AssigneeID:

252638 ⎘